EssilorLuxottica Reports Strong Q4 and 2025 Revenue Growth, Nods to Myopia Management Portfolio

Published on February 12, 2026
PARIS—EssilorLuxottica (Reuters: ESLX.PA) on Wednesday reported 2025 full-year financial results, with consolidated revenue reaching €28,491 million, a year-over-year increase of 11.2 percent at constant exchange rates, compared with full-year 2024. In the fourth quarter of 2025, the company reported consolidated revenue of €7,600 million, up 18.4 percent at constant exchange rates compared with the same period last year. The company attributed the strong performance to, “the depth of our leadership across all our activities and our new categories, capable of generating sustained value for our stakeholders and for the industry as a whole.”
Continue reading on website
Other news

Hoya Vision Care Announces Leadership Changes to Advance North American Commercial, Operational Alignment

February 12, 2026
LEWISVILLE, Texas—Hoya Vision Care, a global leader in ophthalmic lens technology, has announced North American leadership changes designed to strengthen its commercial and operational capabilities. Steven Haifawi, who currently serves as president of Hoya Vision Care Canada, will step into the role of senior vice president, U.S. Commercial, leading the company’s newly unified ECP sales, marketing

New-onset Diplopia May Be Early Warning Sign of GCA

February 12, 2026
Study suggests that diplopia in GCA patients is more frequently reported due to abducens nerve palsy than oculomotor or trochlear nerve palsies. These findings underscore the clinical value of new-onset binocular diplopia as an early warning sign of GCA, warranting prompt investigation and treatment to mitigate risk of further vision loss. Photo: Cecelia Koetting, OD, and Richard Mangan, OD. Click